US Pharma Company, Gilead Sciences, Expands Access to COVID-19 Treatment- Experts Remain Skeptical of Long-Term Demands
As healthcare systems around the world continue to struggle with managing the rates of transmission and mortality in patients with COVID-19, an announcement made in